TP53 and carcinoma: Additionally, the percentage of stromal TILs in TP53 wild type and TP53 mutant low-MD carcinomas were not significantly different in the cohort (Fig. 3d, p = 0.2371), luminal subtype (Fig. 3e, p = 0.3862), or luminal/ductal subtype (Fig. 3f, p = 0.2294); however, the overall number of TP53 mutant cases is small and these data need to be interpreted cautiously.